Noom Healthy Weight Program for Weight Loss

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Weight Loss+4 More
Noom Healthy Weight Program - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will assess the effects of online weight loss programs on liver health in obese adults.

Eligible Conditions
  • Weight Loss
  • Fatty Liver
  • (NAFLD)
  • NASH

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Baseline to day 168

Baseline to day 112
Fibroscan
Fibroscan - from baseline to day 112
Baseline to day 168
Change Weight Efficacy Life-Style (WEL) subscale scores (negative emotion, availability, social pressure, physical discomfort, and positive activities) and a global score
Change in RAND-36 domain scores (emotional well-being, energy/fatigue, general health, pain, physical functioning, role limitations due to emotional problems, role limitations due to physical health, and social functioning).
baseline to day 112
Change in BMI

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Noom Healthy Weight Program
1 of 1
Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Noom Healthy Weight Program · No Placebo Group · N/A

Noom Healthy Weight Program
Behavioral
Experimental Group · 1 Intervention: Noom Healthy Weight Program · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Noom Healthy Weight Program
2021
N/A
~30

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to day 168

Who is running the clinical trial?

Noom Inc.Lead Sponsor
15 Previous Clinical Trials
2,422 Total Patients Enrolled
5 Trials studying Weight Loss
1,106 Patients Enrolled for Weight Loss
Arizona Liver HealthUNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 15th, 2021

Last Reviewed: October 8th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Arizona22.2%
Massachusetts22.2%
California11.1%
Other44.4%
How old are they?
18 - 6585.7%
65+14.3%
What site did they apply to?
Arizona Liver Health100.0%
What portion of applicants met pre-screening criteria?
Met criteria71.4%
Did not meet criteria28.6%